These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 32799866)

  • 1. CircRNAs in anticancer drug resistance: recent advances and future potential.
    Xu T; Wang M; Jiang L; Ma L; Wan L; Chen Q; Wei C; Wang Z
    Mol Cancer; 2020 Aug; 19(1):127. PubMed ID: 32799866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNAs: biogenesis, functions, and role in drug-resistant Tumours.
    Ma S; Kong S; Wang F; Ju S
    Mol Cancer; 2020 Aug; 19(1):119. PubMed ID: 32758239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers.
    Su M; Xiao Y; Ma J; Tang Y; Tian B; Zhang Y; Li X; Wu Z; Yang D; Zhou Y; Wang H; Liao Q; Wang W
    Mol Cancer; 2019 Apr; 18(1):90. PubMed ID: 30999909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs in drug resistant tumors.
    Hua X; Sun Y; Chen J; Wu Y; Sha J; Han S; Zhu X
    Biomed Pharmacother; 2019 Oct; 118():109233. PubMed ID: 31351436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.
    Cui C; Yang J; Li X; Liu D; Fu L; Wang X
    Mol Cancer; 2020 Mar; 19(1):58. PubMed ID: 32171304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the potential of exosomal circular RNAs in mediating cancer chemotherapy resistance and their clinical applications.
    Li Q; Zhang Y; Jin P; Chen Y; Zhang C; Geng X; Mun KS; Phang KC
    Biomed Pharmacother; 2024 Aug; 177():117027. PubMed ID: 38925018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential.
    Mafi A; Hedayati N; Milasi YE; Kahkesh S; Daviran M; Farahani N; Hashemi M; Nabavi N; Alimohammadi M; Rahimzadeh P; Taheriazam A
    Pathol Res Pract; 2024 Aug; 260():155457. PubMed ID: 39018926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance.
    Li J; Sun D; Pu W; Wang J; Peng Y
    Trends Cancer; 2020 Apr; 6(4):319-336. PubMed ID: 32209446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the contribution of circRNAs to cisplatin chemotherapy resistance in cancers.
    Mu C; Wang XL; Ruan Y; Sun JJ; Hu XR; Cheng Y
    Neoplasma; 2021 Nov; 68(6):1119-1131. PubMed ID: 34533032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNAs: The star molecules in cancer.
    Liu J; Li D; Luo H; Zhu X
    Mol Aspects Med; 2019 Dec; 70():141-152. PubMed ID: 31676107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance.
    Ashrafizadeh M; Dai J; Torabian P; Nabavi N; Aref AR; Aljabali AAA; Tambuwala M; Zhu M
    Cell Mol Life Sci; 2024 May; 81(1):214. PubMed ID: 38733529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective.
    Wang T; He M; Zhang X; Guo Z; Wang P; Long F
    Cell Mol Biol Lett; 2024 Apr; 29(1):60. PubMed ID: 38671354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functions and clinical significance of circRNAs in hematological malignancies.
    Zhou X; Zhan L; Huang K; Wang X
    J Hematol Oncol; 2020 Oct; 13(1):138. PubMed ID: 33069241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNAs in lung cancer: implications for preventing therapeutic resistance.
    Liu W; Sun Y; Huo Y; Zhang L; Zhang N; Yang M
    EBioMedicine; 2024 Sep; 107():105309. PubMed ID: 39191172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance.
    Hussen BM; Abdullah SR; Mohammed AA; Rasul MF; Hussein AM; Eslami S; Glassy MC; Taheri M
    Pathol Res Pract; 2024 Aug; 260():155402. PubMed ID: 38885593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).
    Shao Q; Huang Y; Zhang C; Gao X; Gao S
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33786629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs and cancer: Opportunities and challenges.
    Solé C; Lawrie CH
    Adv Clin Chem; 2020; 99():87-146. PubMed ID: 32951640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNAs in cancer: Limitations in functional studies and diagnostic potential.
    Li F; Yang Q; He AT; Yang BB
    Semin Cancer Biol; 2021 Oct; 75():49-61. PubMed ID: 33035655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer.
    Yang X; Ye T; Liu H; Lv P; Duan C; Wu X; Jiang K; Lu H; Xia D; Peng E; Chen Z; Tang K; Ye Z
    Mol Cancer; 2021 Jan; 20(1):4. PubMed ID: 33397425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.